Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Cell|February 21, 2012
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificityEva M Huber, Michael Basler, Ricarda Schwab, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2015
Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine ModelJenny Zilberberg, Jennifer Matos, Eugenia Dziopa, et al.Nature Chemical Biology|March 23, 2024
Global signal peptide profiling reveals principles of selective Sec61 inhibitionNicole A Wenzell, Brian B Tuch, Dustin L McMinn, et al.Plos One|January 5, 2012
Molecular mechanisms of bortezomib resistant adenocarcinoma cellsErika Suzuki, Susan Demo, Edgar Deu, et al.Blood|September 1, 2010
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myelomaDharminder Chauhan, Ajita V Singh, Monette Aujay, et al.British Journal of Haematology|December 1, 2010
PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivoAjita V Singh, Madhavi Bandi, Monette A Aujay, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2011
Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in ratsJinfu Yang, Zhengping Wang, Ying Fang, et al.Cardiovascular Research|December 4, 2022
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosisJun Li, Shaobo Hu, Henry W B Johnson, et al.Chemico-Biological Interactions|September 9, 2008
Endocrine disrupting alkylphenols: structural requirements for their adverse effects on Ca2+ pumps, Ca2+ homeostasis & Sertoli TM4 cell viabilityFrancesco Michelangeli, Oluseye A Ogunbayo, Laura L Wootton, et al.Pageof 6